Jamshid Hadjati
Jamshid Hadjati
Professor of Immunology, School of Medicine, Tehran University of Medical Sciences
Verified email at tums.ac.ir
Title
Cited by
Cited by
Year
Epi-drugs and Epi-miRs: moving beyond current cancer therapies
R Salarinia, A Sahebkar, M Peyvandi, H Reza Mirzaei, M Reza Jaafari, ...
Current cancer drug targets 16 (9), 773-788, 2016
932016
Vaccination-induced autoimmune vitiligo is a consequence of secondary trauma to the skin
C Lane, J Leitch, X Tan, J Hadjati, JL Bramson, Y Wan
Cancer research 64 (4), 1509, 2004
902004
Analysis of class-switched memory B cells in patients with common variable immunodeficiency and its clinical implications
M Vodjgani, A Aghamohammadi, M Samadi, M Moin, J Hadjati, ...
Journal of investigational Allergology and Clinical Immunology 17 (5), 321, 2007
872007
Prospects for chimeric antigen receptor (CAR) γδ T cells: a potential game changer for adoptive T cell cancer immunotherapy
HR Mirzaei, H Mirzaei, SY Lee, J Hadjati, BG Till
Cancer letters 380 (2), 413-423, 2016
832016
CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice
F Jadidi-Niaragh, F Atyabi, A Rastegari, N Kheshtchin, S Arab, ...
Journal of Controlled Release 246, 46-59, 2017
752017
Application of mesenchymal stem cells in melanoma: a potential therapeutic strategy for delivery of targeted agents
H Mirzaei, A Sahebkar, A Avan, M R Jaafari, R Salehi, H Salehi, ...
Current Medicinal Chemistry 23 (5), 455-463, 2016
742016
Bio-hybrid silk fibroin/calcium phosphate/PLGA nanocomposite scaffold to control the delivery of vascular endothelial growth factor
M Farokhi, F Mottaghitalab, MA Shokrgozar, J Ai, J Hadjati, M Azami
Materials Science and Engineering: C 35, 401-410, 2014
602014
Methadone ameliorates multiple-low-dose streptozotocin-induced type 1 diabetes in mice
K Amirshahrokhi, AR Dehpour, J Hadjati, M Sotoudeh, M Ghazi-Khansari
Toxicology and applied pharmacology 232 (1), 119-124, 2008
602008
Upregulation of CD200 is associated with Foxp3+ regulatory T cell expansion and disease progression in acute myeloid leukemia
A Memarian, M Nourizadeh, F Masoumi, M Tabrizi, AH Emami, ...
Tumor Biology 34 (1), 531-542, 2013
552013
Downregulation of CD73 in 4T1 breast cancer cells through siRNA-loaded chitosan-lactate nanoparticles
F Jadidi-Niaragh, F Atyabi, A Rastegari, E Mollarazi, M Kiani, A Razavi, ...
Tumor Biology 37 (6), 8403-8412, 2016
532016
Inhibition of HIF-1α enhances anti-tumor effects of dendritic cell-based vaccination in a mouse model of breast cancer
N Kheshtchin, S Arab, M Ajami, R Mirzaei, M Ashourpour, N Mousavi, ...
Cancer Immunology, Immunotherapy 65 (10), 1159-1167, 2016
482016
PiggyBac as a novel vector in cancer gene therapy: current perspective
H Mirzaei, A Sahebkar, MR Jaafari, J Hadjati, SH Javanmard, HR Mirzaei, ...
Cancer Gene Therapy 23 (2), 45-47, 2016
452016
Immunomodulatory effects of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on differentiation, maturation and endocytosis of monocyte-derived dendritic cells.
M Saeidi, A Masoud, Y Shakiba, J Hadjati, MM Bonab, MH Nicknam, ...
Iranian Journal of Allergy, Asthma and Immunology, 37-49, 2013
452013
Tolerogenic dendritic cells: key regulators of peripheral tolerance in health and disease
A Saei, J Hadjati
International archives of allergy and immunology 161 (4), 293-303, 2013
402013
Anti‐angiogenic effects of CD73‐specific siRNA‐loaded nanoparticles in breast cancer‐bearing mice
G Ghalamfarsa, A Rastegari, F Atyabi, H Hassannia, M Hojjat‐Farsangi, ...
Journal of cellular physiology 233 (10), 7165-7177, 2018
392018
Gene-knocked out chimeric antigen receptor (CAR) T cells: Tuning up for the next generation cancer immunotherapy
HR Mirzaei, H Pourghadamyari, M Rahmati, A Mohammadi, JS Nahand, ...
Cancer letters 423, 95-104, 2018
392018
Increased efficacy of a dendritic cell–based therapeutic cancer vaccine with adenosine receptor antagonist and CD73 inhibitor
S Arab, N Kheshtchin, M Ajami, M Ashurpoor, A Safvati, A Namdar, ...
Tumor Biology 39 (3), 1010428317695021, 2017
352017
In vitro cytotoxicity of four calcium silicate-based endodontic cements on human monocytes, a colorimetric MTT assay
S Khedmat, S Dehghan, J Hadjati, F Masoumi, MH Nekoofar, ...
Restorative dentistry & endodontics 39 (3), 149-154, 2014
312014
Dendritic cell based immunotherapy using tumor stem cells mediates potent antitumor immune responses
A Dashti, M Ebrahimi, J Hadjati, A Memarnejadian, SM Moazzeni
Cancer Letters 374 (1), 175-185, 2016
302016
Structural and functional changes of silk fibroin scaffold due to hydrolytic degradation
M Farokhi, F Mottaghitalab, J Hadjati, R Omidvar, M Majidi, A Amanzadeh, ...
Journal of Applied Polymer Science 131 (6), 2014
292014
The system can't perform the operation now. Try again later.
Articles 1–20